The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(5-((4-Nitrobenzyl)thio)-1,3,4-thiadiazol-2-yl)nicotinamide ID: ALA4590984
PubChem CID: 46937358
Max Phase: Preclinical
Molecular Formula: C15H11N5O3S2
Molecular Weight: 373.42
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(Nc1nnc(SCc2ccc([N+](=O)[O-])cc2)s1)c1cccnc1
Standard InChI: InChI=1S/C15H11N5O3S2/c21-13(11-2-1-7-16-8-11)17-14-18-19-15(25-14)24-9-10-3-5-12(6-4-10)20(22)23/h1-8H,9H2,(H,17,18,21)
Standard InChI Key: ZTDOJPCUIXALSV-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
7.6985 -12.1989 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
6.9404 -12.5191 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0129 -13.3371 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.8133 -13.5214 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.2364 -12.8175 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0505 -12.7463 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.2400 -12.0980 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
5.5252 -12.4939 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8248 -12.0728 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8422 -11.2555 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1427 -10.8345 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4268 -11.2305 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4149 -12.0518 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1150 -12.4691 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7235 -10.8103 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.0091 -11.2072 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.7369 -9.9932 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.5192 -13.4157 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3333 -13.3445 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1738 -14.1563 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.8007 -14.0147 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6141 -13.9439 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.9602 -13.2027 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4869 -12.5313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6752 -12.6054 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 2 0
1 2 1 0
3 4 1 0
4 5 2 0
5 1 1 0
5 6 1 0
2 7 1 0
7 8 1 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 9 1 0
15 16 2 0
15 17 1 0
12 15 1 0
6 18 1 0
18 19 1 0
18 20 2 0
19 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 19 1 0
M CHG 2 15 1 17 -1
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 373.42Molecular Weight (Monoisotopic): 373.0303AlogP: 3.39#Rotatable Bonds: 6Polar Surface Area: 110.91Molecular Species: NEUTRALHBA: 8HBD: 1#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 8.06CX Basic pKa: 3.49CX LogP: 3.18CX LogD: 3.10Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.31Np Likeness Score: -2.68
References 1. Wehrli PM, Uzelac I, Olsson T, Jacso T, Tietze D, Gottfries J.. (2019) Discovery and development of substituted thiadiazoles as inhibitors of Staphylococcus aureus Sortase A., 27 (19): [PMID:31420255 ] [10.1016/j.bmc.2019.115043 ]